| 1 |
Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus |
|
| | Maka Siamashvili, Stephen Davis | | | Expert Opinion on Pharmacotherapy. 2021; 22(2): 241 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials |
|
| | Ida Brandt Andersen, Mikkel Andreassen, Jesper Krogh | | | Diabetes, Obesity and Metabolism. 2021; 23(1): 58 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus |
|
| | Alfredo Briones-Aranda, Javier Ramírez-Carballo, Bernardo Alfredo Romero Gómez, Victor Manuel Vega Villa, Manuela Castellanos Pérez, Esmeralda Garcia Parra, Hugo Roberto Santeliz-Montero | | | Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2018; 25(1): 59 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases |
|
| | Alexander O Shpakov, Kira V Derkach, Lev M Berstein | | | Future Science OA. 2015; 1(3) | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Pharmacological treatment of diabetes in older people |
|
| | W. M. Valencia,H. Florez | | | Diabetes, Obesity and Metabolism. 2014; : n/a | | | [Pubmed] [Google Scholar] [DOI] | |
|
